Admission Date:  [**2172-2-6**]     Discharge Date:  [**2172-2-18**]  Date of Birth:   [**2104-12-24**]     Sex:  F   HISTORY OF PRESENT ILLNESS:  This is a 67-year-old female with a history of chronic obstructive pulmonary disease, emphysema (forced expiratory volume 0.59) on home oxygen 2 liters nasal cannula and smokes two packs per day who infection symptoms for three days including a cough at baseline and sputum eight days prior Emergency Room admission on [**2172-2-6**] PEEP.
She was placed on nasal BiPAP, albuterol and Atrovent Emergency Room, and her oxygen saturation increased to 90% to 91%, and her arterial blood gas revealed a pH of 7.42, PCO2 of 74, and PO2 of 120.
She was treated with amantadine and levofloxacin.
She was weaned from BiPAP to 2 liters nasal cannula with an oxygen saturation of 90% to 91% at rest, but had decreasing oxygen saturations to 70% with activity.
She was continued on her Flomax, albuterol, and Atrovent nebulizers, and prednisone 20 mg q.d.
On admission, her hematocrit was 55.4 and was 55.4 secondary to her history of polycythemia, and was due for a blood removal the day after admission.
History of tuberculosis; childhood, has had no reactivation, plus purified protein derivative, status post treatment at age of five years old, multiple sputum negative for acid-fast bacillus.
MEDICATIONS ON TRANSFER:  Levofloxacin 250 mg p.o.
q.d., Navane 2 mg p.o.
q.h.s., Volmax 4 mg p.o.
q.h.s., enteric-coated aspirin 325 mg p.o.
q.d., Zantac 150 mg p.o.
b.i.d., Serax 10 mg p.o.
t.i.d., Atrovent meter-dosed inhaler 1 nebulizer q.4h., albuterol 1 nebulizer q.4h., prednisone 40 mg p.o.
q.d., Atrovent nebulizers one treatment q.1-2h.
for dyspnea, albuterol 2 puffs inhaler q.3-4h., Tegretol 200 mg p.o.
ALLERGIES:  CODEINE (stomatitis), PHENOBARBITAL (temperature variations), LITHIUM (increase in creatinine).
HOSPITAL COURSE:  The patient is a 76-year-old female with severe chronic obstructive pulmonary disease, emphysema, who smokes two packs per day, and is on home oxygen, who was admitted to the Medical Intensive Care Unit for respiratory failure due to a chronic obstructive pulmonary disease flare secondary to influenza infection and is now transferred to the Medicine Service after being weaned from BiPAP for continued management of her chronic obstructive pulmonary disease flare.
PULMONARY:  The patient apparently on levofloxacin to prevent secondary bacterial pneumonia, status post influenza infection, and is on prednisone for treatment of chronic obstructive pulmonary disease flare.
The levofloxacin was discontinued on hospital day two, and the patient continued to have baseline cough with baseline slight tan sputum.
The patient was continued on her Atrovent and albuterol nebulizers p.r.n., albuterol inhaler, and prednisone taper.
Withdraw of blood was not considered necessary unless her hematocrit increased to 50.
PSYCHIATRY:  The patient was continued on her psychiatric medications for her bipolar disorder.
Additionally, she was placed on Serax t.i.d.
The patient tended to become anxious when she had difficulty breathing, and Serax helped improve her symptoms of dyspnea.
DISCHARGE STATUS:  The patient was discharged to home with a nebulizer machine from which she would take Atrovent and albuterol nebulizers in the a.m. and Atrovent and albuterol inhalers p.r.n.
She was also continuing her prednisone taper.
The patient was referred for home physical therapy and [**Hospital6 407**].
Premarin 0.625 mg p.o.
Serax 10 mg p.o.
Atrovent nebulizers and albuterol nebulizers times one q.a.m., Atrovent meter-dosed inhaler 2 to 4 puffs q.4-6h.
for dyspnea, albuterol meter-dosed inhaler 2 to 4 puffs q.4-6h.
Prednisone taper 20 mg p.o.
Navane 2 mg p.o.
Volmax 4 mg p.o.
Enteric-coated aspirin 325 mg p.o.
Zantac 150 mg p.o.
Tegretol 200 mg p.o.
Flovent 100 mcg meter-dosed inhaler 4 puffs b.i.d.
Colace 100 mg p.o.
Protonix 40 mg p.o.
